Daewon Pharmaceutical Acquires 14.1 Billion KRW Worth of Geukdong Echipham Shares... 83.5% Stake
[Asia Economy Reporter Park Jihwan] Daewon Pharmaceutical announced on the 12th that it will acquire 59,793 shares of Geukdong Echipham, a health functional food manufacturing and sales company, for approximately 14.1 billion KRW.
After acquiring the shares, Daewon Pharmaceutical's stake in Geukdong Echipham will be 83.51%. The scheduled date for the share acquisition is the 26th of this month.
Hot Picks Today
Samsung Electronics Introduces New "Special Performance Bonus" for Semiconductors, Paid Entirely in Company Shares
- "Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- Hyundai Mobis, Key Supplier for Hyundai’s Atlas, Target Price Raised [Click eStock]
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Daewon Pharmaceutical stated that the purpose of this share acquisition is "to expand entry into the health functional food sector and increase corporate value."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
